Denmark is one of the most R&D intensive countries in the world and the best in Europe in terms of researcher concentration. With access to specialised talent and a highly productive and innovative biotech industry, Denmark is a very attractive location to place your research activities.
Whether your company is looking for R&D collaborations, investment or expansion opportunities, Denmark has a strong offering as a global hub in the biotech industry.
Overall, Denmark has the 3rd largest commercial drug development pipeline in Europe. On a per capita basis, we have the world’s highest percentage of patents in biotechnology and the highest number of biotech companies. Denmark is also the country that conducts the most clinical trials per capita.
Denmark offers therapeutic areas of excellence in metabolic diseases, central nervous system, oncology and inflammatory and infectious diseases – as part of Medicon Valley, a strong healthcare research community and one of Europe’s strongest life science clusters. We provide access to a world-class talent pool and academic institutions of proven excellence, world-class patient registries, civil registries and biobanks, and access to excellent infrastructure including the world’s leading centre for life sciences and materials research: ESS and MAX IV.
Learn more about our world-leading biotech industry here.